Higher serum testosterone levels predict poor prognosis in castration‐resistant prostate cancer patients treated with docetaxel-Reference-Cited by-同舟云学术

Higher serum testosterone levels predict poor prognosis in castration‐resistant prostate cancer patients treated with docetaxel

Published:2019-12-09 Issue:3 Volume:80 Page:247-255
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Ando Keisuke¹,Sakamoto Shinichi¹^ORCID,Takeshita Nobushige¹,Fujimoto Ayumi¹,Maimaiti Maihulan¹,Saito Shinpei²,Sanjyon Pae³,Imamura Yusuke¹,Sato Nobuo²,Komiya Akira¹,Akakura Koichiro⁴,Ichikawa Tomohiko¹

Affiliation:

1. Department of UrologyChiba University HospitalChiba Japan

2. Department of UrologyFunabashi Municipal Medical CenterChiba Japan

3. Department of UrologyChiba Cancer CenterChiba Japan

4. Department of UrologyJapan Community Healthcare Organization Tokyo Shinjuku Medical CenterChiba Japan

Funder

Grant-in-Aid for Scientific Researc

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.23938

Reference26 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

2. Cancer Cancer Registry and Statistics. Cancer mortality and incidence. Cancer Information Service National Cancer Center Japan.http://ganjoho.jp/reg_stat/statistics/dl/index.html. Accessed 14 December2018

3. Role of Androgen Receptor in Prostate Cancer: A Review

4. Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care?;Klotz L;Current Oncology,2012

5. A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermittent Androgen Deprivation Therapy for Biochemical Recurrence following Radical Local Therapy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix;The Prostate;2024-02-27

2. Copy Number Gain in Androgen Receptors Predicts the Poor Prognosis in Japanese Castration-resistant Prostate Cancer;Anticancer Research;2024-02

3. Pros and cons of hormone replacement therapy;Scientific Bulletin of the Omsk State Medical University;2023

4. Revision of CHAARTED and LATITUDE criteria among Japanese de novo metastatic prostate cancer patients;Prostate International;2021-12

5. Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor;Cancer Science;2021-07-08